Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Ermert

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Chimia|October 27, 2017
Design, Properties and Recent Application of Macrocycles in Medicinal ChemistryPhilipp Ermert
Medicine in Drug Discovery|January 5, 2021
Emerging peptide antibiotics with therapeutic potentialGregory Upert, Anatol Luther, Daniel Obrecht, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 29, 2019
Frontier Between Cyclic Peptides and MacrocyclesPhilipp Ermert, Anatol Luther, Peter Zbinden, et al.
Chimia|July 8, 2021
Macrocycle Therapeutics to Treat Life-threatening DiseasesGokhan Batur, Philipp Ermert, Johann Zimmermann, et al.
Journal of Medicinal Chemistry|March 21, 2003
Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitorsKevin E B Parkes, Philipp Ermert, Jürg Fässler, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Chimia|October 27, 2017
Design, Properties and Recent Application of Macrocycles in Medicinal ChemistryPhilipp Ermert
Medicine in Drug Discovery|January 5, 2021
Emerging peptide antibiotics with therapeutic potentialGregory Upert, Anatol Luther, Daniel Obrecht, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 29, 2019
Frontier Between Cyclic Peptides and MacrocyclesPhilipp Ermert, Anatol Luther, Peter Zbinden, et al.
Chimia|July 8, 2021
Macrocycle Therapeutics to Treat Life-threatening DiseasesGokhan Batur, Philipp Ermert, Johann Zimmermann, et al.
Journal of Medicinal Chemistry|March 21, 2003
Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitorsKevin E B Parkes, Philipp Ermert, Jürg Fässler, et al.
Pageof 1